BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 17119030)

  • 1. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
    Smedby KE; Askling J; Mariette X; Baecklund E
    J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
    Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
    Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.
    Baecklund E; Iliadou A; Askling J; Ekbom A; Backlin C; Granath F; Catrina AI; Rosenquist R; Feltelius N; Sundström C; Klareskog L
    Arthritis Rheum; 2006 Mar; 54(3):692-701. PubMed ID: 16508929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?
    Yadlapati S; Efthimiou P
    Biomed Res Int; 2016; 2016():8631061. PubMed ID: 27429984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
    Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
    Voulgarelis M; Moutsopoulos HM
    Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.
    Hansen A; Lipsky PE; Dörner T
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):561-9. PubMed ID: 17906611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
    Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.